Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1991 1
1995 3
1996 1
1997 2
1999 1
2002 6
2003 3
2004 2
2005 3
2006 4
2007 3
2008 2
2009 10
2010 2
2011 3
2012 4
2013 3
2014 4
2015 4
2016 2
2017 9
2018 3
2019 1
2020 1
2021 2
2022 1
2023 1
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F; RAISE Study Investigators. Tabernero J, et al. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Lancet Oncol. 2015. PMID: 25877855 Clinical Trial.
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Bennouna J, Sastre J, Arnold D, Österlund P, Greil R, Van Cutsem E, von Moos R, Viéitez JM, Bouché O, Borg C, Steffens CC, Alonso-Orduña V, Schlichting C, Reyes-Rivera I, Bendahmane B, André T, Kubicka S; ML18147 Study Investigators. Bennouna J, et al. Lancet Oncol. 2013 Jan;14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. Epub 2012 Nov 16. Lancet Oncol. 2013. PMID: 23168366 Clinical Trial.
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.
Hammel P, Huguet F, van Laethem JL, Goldstein D, Glimelius B, Artru P, Borbath I, Bouché O, Shannon J, André T, Mineur L, Chibaudel B, Bonnetain F, Louvet C; LAP07 Trial Group. Hammel P, et al. JAMA. 2016 May 3;315(17):1844-53. doi: 10.1001/jama.2016.4324. JAMA. 2016. PMID: 27139057 Clinical Trial.
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.
Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A; FOXFIRE trial investigators; SIRFLOX trial investigators; FOXFIRE-Global trial investigators; van Hazel G, Sharma RA. Wasan HS, et al. Lancet Oncol. 2017 Sep;18(9):1159-1171. doi: 10.1016/S1470-2045(17)30457-6. Epub 2017 Aug 3. Lancet Oncol. 2017. PMID: 28781171 Free PMC article. Clinical Trial.
[Radiotherapy in rectal cancer: when, why and how?].
Martinive P, Vandaele D, Lennerts E, Polus M, Coimbra C, Kohnen L, Vanderick J, Collignon J, Coucke P. Martinive P, et al. Among authors: polus m. Rev Med Liege. 2014;69 Suppl 1:37-46. Rev Med Liege. 2014. PMID: 24822304 Free article. Review. French.
Familial adenomatous polyposis: clinical presentation, detection and surveillance.
Laurent S, Franchimont D, Coppens JP, Leunen K, Macken L, Peeters M, Plomteux O, Polus M, Poppe B, Sempoux C, Tejpar S, Van Den Eynde M, Van Gossum A, Vannoote J, Kartheuser A, Van Cutsem E. Laurent S, et al. Among authors: polus m. Acta Gastroenterol Belg. 2011 Sep;74(3):415-20. Acta Gastroenterol Belg. 2011. PMID: 22103047 Free article. Review.
[Primary and secondary prevention of colorectal cancer].
Polus M, Piront P, Jerusalem G, Sautois B, Louis E, Detroz B, Laurent S, Belaiche J, Fillet G. Polus M, et al. Rev Med Liege. 2003 Apr;58(4):247-53. Rev Med Liege. 2003. PMID: 12868329 Free article. Review. French.
Decision aids for female BRCA mutation carriers: a scoping review.
McGarrigle SA, Prizeman G, Spillane C, Byrne N, Drury A, Polus M, Mockler D, Connolly EM, Brady AM, Hanhauser YP. McGarrigle SA, et al. Among authors: polus m. BMJ Open. 2024 Jun 13;14(6):e076876. doi: 10.1136/bmjopen-2023-076876. BMJ Open. 2024. PMID: 38871662 Free PMC article.
[Comprehensive therapeutic strategy for localized esophageal cancer].
Van Daele D, Honoré P, Collignon J, Polus M, Loly C, Mutijima E, De Roover A, Coucke PA, Louis E, Martinive P. Van Daele D, et al. Among authors: polus m. Rev Med Liege. 2017 Feb;72(2):58-63. Rev Med Liege. 2017. PMID: 28387081 Free article. Review. French.
83 results